Covered recipient · General Payments record
STEVEN M LOBEL
Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine
General Payments · PY2018–2024
$5,952.83
- Reported across 206 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,040.90 | 25 |
| Consulting Fee | $725.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | $834.20 | 2 |
| Nevro Corp. | $567.85 | 11 |
| Radius Health, Inc. | $143.64 | 2 |
| Abbott Laboratories | $55.21 | 2 |
| Amgen Inc. | $52.19 | 3 |
| Novo Nordisk AS | $32.12 | 2 |
| Medtronic, Inc. | $25.07 | 1 |
| GlaxoSmithKline, LLC. | $25.02 | 1 |
| Phathom Pharmaceuticals, Inc. | $15.51 | 1 |
| Saluda Medical Americas, Inc. | $15.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $25.32 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125319575 | CMS |
| Abbott Laboratories | $29.89 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125319577 | CMS |
| Alexion Pharmaceuticals, Inc. | $109.20 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1094032968 | CMS |
| Alexion Pharmaceuticals, Inc. | $725.00 | 09/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1094034380 | CMS |
| Amgen Inc. | $22.35 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115878894 | CMS |
| Amgen Inc. | $13.55 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115878902 | CMS |
| Amgen Inc. | $16.29 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115878912 | CMS |
| GlaxoSmithKline, LLC. | $25.02 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116390394 | CMS |
| Medtronic, Inc. | $25.07 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119530913 | CMS |
| Nevro Corp. | $104.49 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727788 | CMS |
| Nevro Corp. | $39.27 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727758 | CMS |
| Nevro Corp. | $38.35 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727756 | CMS |
| Nevro Corp. | $38.68 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727796 | CMS |
| Nevro Corp. | $68.43 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727752 | CMS |
| Nevro Corp. | $41.02 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727728 | CMS |
| Nevro Corp. | $27.07 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727824 | CMS |
| Nevro Corp. | $13.82 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727754 | CMS |
| Nevro Corp. | $47.77 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727810 | CMS |
| Nevro Corp. | $131.08 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727798 | CMS |
| Nevro Corp. | $17.87 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130727760 | CMS |
| Novo Nordisk Inc | $15.97 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096967522 | CMS |
| Novo Nordisk Inc | $16.15 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097410887 | CMS |
| Phathom Pharmaceuticals, Inc. | $15.51 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151089843 | CMS |
| Radius Health, Inc. | $116.04 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089995102 | CMS |
| Radius Health, Inc. | $27.60 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089995096 | CMS |
| Saluda Medical Americas, Inc. | $15.09 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081869026 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.